# NewAmsterdam Pharma (NAMS) — Overview

NAMS · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/nams

## Price

Last close $20.62 on Oct 15, 2026. 52-week range $20.01 – $41.45.

## Company profile

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments. The Company has one reportable segment, which comprises the discovery, development, and commercialization of transformative therapies for cardio-metabolic diseases.

## Financials

| Metric | Value |
| --- | --- |
| Revenue (trailing twelve months) | $7.1M |
| Revenue (quarter) | $3.7M |
| Revenue growth (year over year) | -80.67% |
| Gross profit (trailing twelve months) | $7.1M |
| Gross margin | 100.00% |
| Net income (trailing twelve months) | −$259.5M |
| Net income (quarter) | −$64.1M |
| Net income growth (year over year) | -269.36% |
| Net margin | -3644.21% |
| Return on equity | -36.81% |
| EPS (trailing twelve months) | −$2.16 |
| Book value per share | $5.37 |
| P/E (trailing twelve months) | — |
| Price to book | 3.9 |
| Debt to assets | 10.37% |
| Payout ratio | 0.00% |
| Dividend yield | 0.00% |

## Frequently Asked Questions

### Is NewAmsterdam Pharma (NAMS) profitable?

No. NewAmsterdam Pharma reported a net loss of $259.5M over the trailing twelve months.

### How much revenue does NewAmsterdam Pharma (NAMS) make?

NewAmsterdam Pharma generated $7.1M in revenue over the trailing twelve months, down 80.67% year over year.

### How do I buy stock in NewAmsterdam Pharma (NAMS)?

NAMS trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).